Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) posted Non-Current Debt of $1 million for the year ended Dec 31, 2025.

Analysis

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025) Analysis & Trends

  • Annual Non-Current Debt shows a three-year compound annual growth rate of 206.7% (years ended Dec 2022 to Dec 2025).
  • The figure for the year ended Dec 31, 2025 stands as the lowest annual Non-Current Debt since the year ended Dec 31, 2022.
  • Business Quant data shows ZYBT's Non-Current Debt at $34,702 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 62.48 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 60.50 Bn
10 Zhengye Biotechnology Holding 70.08 Mn 58.36 Mn - 1.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.26 Mn
Jun 30, 2025 656,000.00
Dec 31, 2024 657,705.40
Dec 31, 2023 1.41 Mn
API Access

Zhengye Biotechnology Holding Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ZYBT&period=max&api_key=YOUR_API_KEY